What's in Gruppo Italiano Studio Linfomi's pipeline?

Gruppo Italiano Studio Linfomi has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Gruppo Italiano Studio Linfomi's portfolio?

Top competitors by shared drug class: SWOG Cancer Research Network, Nationwide Children's Hospital, Grupo de Estudos Multicentricos em Onco-Hematologia, Polish Adult Leukemia Group, Shandong New Time Pharmaceutical Co., LTD.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gruppo-italiano-studio-linfomi.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Gruppo Italiano Studio Linfomi — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gruppo Italiano Studio Linfomi pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
COPPEBVCAD vs BEACOPP vs ABVD	COPPEBVCAD vs BEACOPP vs ABVD	phase 3	Polychemotherapy regimen	Oncology
HDS vs ProMECE/CytaBOM	HDS vs ProMECE/CytaBOM	phase 3	Multi-agent chemotherapy regimen	Oncology
Melphalan, Prednisone and Thalidomide	Melphalan, Prednisone and Thalidomide	phase 3	Combination chemotherapy with immunomodulatory agent	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

SWOG Cancer Research Network · 2 shared drug classes
Nationwide Children's Hospital · 2 shared drug classes
Grupo de Estudos Multicentricos em Onco-Hematologia · 1 shared drug class
Polish Adult Leukemia Group · 1 shared drug class
Shandong New Time Pharmaceutical Co., LTD · 1 shared drug class
St. Jude Children's Research Hospital · 1 shared drug class
Children's Cancer Group, China · 1 shared drug class
University of Cologne · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gruppo Italiano Studio Linfomi:

Cite this brief

Drug Landscape (2026). Gruppo Italiano Studio Linfomi — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gruppo-italiano-studio-linfomi. Accessed 2026-05-16.